What estrogen‑free contraceptive options are appropriate for a 19‑year‑old woman with a new left‑leg deep vein thrombosis who is taking apixaban (Eliquis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Contraception After DVT: Switch to Progestin-Only Methods

This patient must immediately discontinue her combined hormonal contraceptive (which contains estrogen) and switch to a progestin-only contraceptive method, as estrogen-containing contraceptives are absolutely contraindicated in anyone with a history of venous thromboembolism. 1

Why Estrogen-Containing Birth Control Must Be Stopped

Combined hormonal contraceptives (pills, patches, or vaginal rings containing estrogen) induce a hypercoagulable state and significantly increase VTE risk—this is primarily driven by the estrogenic component 2. Women with a history of DVT who are not receiving anticoagulation therapy have an absolute contraindication to combined hormonal contraceptives 2. Even though this patient is currently anticoagulated on apixaban, the estrogen must be discontinued before she completes her anticoagulation course.

Safe Contraceptive Options

Progestin-Only Methods (All Safe Options)

The following progestin-only contraceptives do not increase thrombotic risk and are appropriate for women with prior VTE 1, 3:

  • Progestin-only pills (POPs): No association with increased VTE risk 3
  • Etonogestrel implant (Nexplanon): No increased VTE risk 3
  • Levonorgestrel intrauterine device (Mirena, Kyleena, Skyla, Liletta): No increased VTE risk and offers the additional benefit of reducing menstrual bleeding, which is particularly advantageous while on anticoagulation 1, 3

Special Consideration for DMPA

Depot medroxyprogesterone acetate (Depo-Provera) should be avoided in this patient. While most progestin-only methods are safe, limited evidence suggests DMPA may double the risk of VTE 3, 4. Given that safer alternatives exist, DMPA is not the optimal choice for someone with established thrombosis.

Long-Acting Reversible Contraception (LARC) Advantages

The levonorgestrel IUD is particularly advantageous for this patient because:

  • It provides highly effective contraception without thrombotic risk
  • It reduces menstrual bleeding, which helps minimize bleeding complications while she remains on apixaban 1
  • It requires no daily adherence
  • It remains safe and effective long-term, even after anticoagulation is discontinued

Timing of Contraceptive Switch

The switch from combined hormonal contraception to progestin-only methods should occur immediately—there is no need to wait. The patient can start a progestin-only method right away while continuing apixaban 1. If switching to an IUD, she can have it placed at any time, ideally coordinating with her menstrual cycle for ease of insertion, but this is not mandatory.

Critical Pitfall to Avoid

Do not allow this patient to resume combined hormonal contraceptives after completing anticoagulation therapy. The history of provoked or unprovoked DVT creates a permanent contraindication to estrogen-containing contraceptives, even after the acute event has resolved and anticoagulation has been discontinued 2, 1.

Non-Hormonal Alternatives

If the patient prefers to avoid all hormonal methods, the copper IUD (Paragard) is another excellent option with no thrombotic risk and high efficacy. Barrier methods (condoms, diaphragm) are also safe but less effective for pregnancy prevention.

Related Questions

In a female patient who developed deep vein thrombosis (DVT) of the right femoral vein after cardiac catheterization and is on apixaban (Eliquis) for coronary stents, how long should we wait before performing staged pulmonary vein isolation (PVI)?
In a 74-year-old bedridden woman with a prior history of deep vein thrombosis treated with apixaban (Eliquis) for 7 months and chronic residual thrombosis, and a current duplex ultrasound showing no acute DVT, should anticoagulation be restarted?
In a patient with deep vein thrombosis who underwent surgery and has a small amount of bleeding from nephrostomy drains, should apixaban (Eliquis) be held?
What is the appropriate apixaban dosing regimen for a 16‑kg child with a proximal deep vein thrombosis?
What is the recommended dosing regimen of apixaban for treatment and prophylaxis of venous thromboembolism in adults, including adjustments for age, weight, and renal function?
What is the most likely diagnosis and recommended workup and management for a 2.9 × 1.7 cm lesion in the distal femoral metaphysis with mixed signal intensity, arc‑and‑ring appearance, and circumscribed sclerotic borders?
Can a patient who was previously on ezetimibe (Zetia) and stopped it to start icosapent ethyl (Vascepa) plus coenzyme Q10 restart ezetimibe now that LDL has risen?
What should be the next steps in managing a patient taking mirtazapine 7.5 mg who is confused, excessively sleepy, experiencing racing thoughts, and unable to get out of bed?
What are the possible causes of a four-week history of dysphonia in a 73-year-old non-smoker?
What is the recommended medication regimen for treating depression in a pregnant woman?
What are the commercial (brand) names for escitalopram 5 mg tablets?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.